United States · Series A startup

Who invested in Alveus Therapeutics Inc.

One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$197Mraised across 1 round since 2026, from 2 sources

Latest round
Series A, $197MFeb 2026
Led by
Omega Funds and Andera Partnersand 1 more
Investors
9 (3 led)
See who backed them

The rounds

  1. Feb 2026
    Series A$197M

    Reported by Seroba Life Sciences and 1 otherSEC filing: $57M sold, first sale Dec 2025

Founders and team

From Alveus Therapeutics Inc.'s own website: 6 on the team.

  • Raj KannanCEO
  • Claudio NessiBoard Member
  • Erik VoorspoelsDirector of Finance & Operations
  • Garrett IngramBoard Member
  • Jan Van den BosscheBoard Member
  • Ksenija PavleticBoard Member

Everyone who backed them

Omega FundsVC firm1round, led 1
Andera PartnersPrivate equity1round, led 1
New RheinPrivate equity1round, led 1
Novo HoldingsVC firm1round
SanofiInvestment firm1round
KurmaPartnersVC firm1round
Seroba.VC firm1round
Jeito CapitalVC firm1round
Avego Bioscience CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Alveus Therapeutics Inc.

Who invested in Alveus Therapeutics Inc.?

Alveus Therapeutics Inc.'s investors include Omega Funds, Andera Partners, New Rhein, Novo Holdings and Sanofi, and 4 more on record. Omega Funds led its latest round.

How much has Alveus Therapeutics Inc. raised?

Alveus Therapeutics Inc. has raised $197M across 1 round since 2026.

When did Alveus Therapeutics Inc. last raise?

Alveus Therapeutics Inc.'s most recent round was a Series A of $197M in Feb 2026, led by Omega Funds.

What was Alveus Therapeutics Inc.'s biggest round?

Its most recent round, $197M in Feb 2026, is also its largest on record.

Who backed Alveus Therapeutics Inc. first?

Alveus Therapeutics Inc.'s first round on record, in Feb 2026, was backed by Omega Funds, Andera Partners and New Rhein and 6 others.

What stage is Alveus Therapeutics Inc. at?

Alveus Therapeutics Inc.'s latest named round is a Series A, in Feb 2026.

Where is Alveus Therapeutics Inc. based?

Alveus Therapeutics Inc. is based in the United States.

Who led Alveus Therapeutics Inc.'s rounds?

Omega Funds led the Series A in 2026.

Companies like Alveus Therapeutics Inc.

In the same sector, and raised in the last eighteen months.

Star Therapeutics$325M · Oct 2026Promaxo$106M · Oct 2026Prolific Machines$105M · Oct 2026IMIO$19M · Oct 2026Clinical Ink$24M · Oct 2026Rejuvenate Bio$13M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app